Advertisement
Canada markets closed
  • S&P/TSX

    24,471.17
    +168.87 (+0.69%)
     
  • S&P 500

    5,857.67
    +42.64 (+0.73%)
     
  • DOW

    43,049.70
    +185.84 (+0.43%)
     
  • CAD/USD

    0.7249
    -0.0021 (-0.29%)
     
  • CRUDE OIL

    74.00
    -1.56 (-2.06%)
     
  • Bitcoin CAD

    90,574.38
    +4,118.41 (+4.76%)
     
  • XRP CAD

    0.75
    +0.02 (+3.08%)
     
  • GOLD FUTURES

    2,665.30
    -11.00 (-0.41%)
     
  • RUSSELL 2000

    2,245.18
    +10.77 (+0.48%)
     
  • 10-Yr Bond

    4.0980
    +0.0250 (+0.61%)
     
  • NASDAQ

    18,501.28
    +158.34 (+0.86%)
     
  • VOLATILITY

    19.79
    -0.67 (-3.27%)
     
  • FTSE

    8,292.66
    +39.01 (+0.47%)
     
  • NIKKEI 225

    39,605.80
    +224.90 (+0.57%)
     
  • CAD/EUR

    0.6646
    +0.0004 (+0.06%)
     

Returns On Capital At EMS-CHEMIE HOLDING (VTX:EMSN) Have Stalled

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Having said that, while the ROCE is currently high for EMS-CHEMIE HOLDING (VTX:EMSN), we aren't jumping out of our chairs because returns are decreasing.

Understanding Return On Capital Employed (ROCE)

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for EMS-CHEMIE HOLDING:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.31 = CHF611m ÷ (CHF2.3b - CHF374m) (Based on the trailing twelve months to December 2022).

So, EMS-CHEMIE HOLDING has an ROCE of 31%. In absolute terms that's a great return and it's even better than the Chemicals industry average of 12%.

Check out our latest analysis for EMS-CHEMIE HOLDING

roce
roce

In the above chart we have measured EMS-CHEMIE HOLDING's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

What Does the ROCE Trend For EMS-CHEMIE HOLDING Tell Us?

There hasn't been much to report for EMS-CHEMIE HOLDING's returns and its level of capital employed because both metrics have been steady for the past five years. It's not uncommon to see this when looking at a mature and stable business that isn't re-investing its earnings because it has likely passed that phase of the business cycle. Although current returns are high, we'd need more evidence of underlying growth for it to look like a multi-bagger going forward. That being the case, it makes sense that EMS-CHEMIE HOLDING has been paying out 86% of its earnings to its shareholders. If the company is in fact lacking growth opportunities, that's one of the viable alternatives for the money.

In Conclusion...

Although is allocating it's capital efficiently to generate impressive returns, it isn't compounding its base of capital, which is what we'd see from a multi-bagger. Unsurprisingly, the stock has only gained 32% over the last five years, which potentially indicates that investors are accounting for this going forward. As a result, if you're hunting for a multi-bagger, we think you'd have more luck elsewhere.

If you'd like to know about the risks facing EMS-CHEMIE HOLDING, we've discovered 1 warning sign that you should be aware of.

High returns are a key ingredient to strong performance, so check out our free list ofstocks earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here